Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Medical Informatics and Decision Making|December 25, 2015
Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at homeL M Wintner, J M Giesinger, A Zabernigg, et al.
Leukemia Research|June 27, 2000
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot studyT Kühr, W Eisterer, U Apfelbeck, et al.
Annals of Surgical Oncology|November 11, 2010
Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility studyG Spizzo, D Öfner, A de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2010
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categoriesM Fiegl, M Erdel, I Tinhofer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphomaM A Fridrik, G Jäger, H R Kienzer, et al.
Annals of Hematology|December 3, 2013
Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patientsM Fiegl, R Stauder, M Steurer, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trialM Schmidinger, A C Budinsky, C Wenzel, et al.
Leukemia Research|March 7, 2003
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)T Kühr, S Burgstaller, U Apfelbeck, et al.
Pageof 2